Responses
Late-breaking abstracts
Clinical trials in-progress
805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours
Compose a Response to This Article
Other responses
No responses have been published for this article.